Comparison between Cell Point IPO and Vilin Bio Med IPO.
Cell Point IPO is a SME Fixed Price IPO proposed to list at NSE SME while Vilin Bio Med IPO is a SME Fixed Price proposed to list at NSE SME.
| Cell Point IPO | Vilin Bio Med IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | First Overseas Capital Ltd. | Inventure Merchant Banker Services Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | NNM Securities Pvt.Ltd. | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Cell Point IPO is up to ₹47.82 Cr whereas the issue size of the Vilin Bio Med IPO is up to ₹11.38 Cr. The final issue price of Cell Point IPO is ₹100.00 per share and of Vilin Bio Med IPO is ₹30.00 per share.
| Cell Point IPO | Vilin Bio Med IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹100.00 per share | ₹30.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 4000 shares |
| Fresh Issue Size | 47,82,000 shares | 37,92,000 shares |
| Fresh Issue Size (Amount) | up to ₹47.82 Cr | up to ₹11.38 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 47,82,000 shares | 37,92,000 shares |
| Issue Size Total (Amount) | up to ₹47.82 Cr | up to ₹11.38 Cr |
Cell Point IPO opens on Jun 15, 2023, while Vilin Bio Med IPO opens on Jun 16, 2023. The closing date of Cell Point IPO and Vilin Bio Med IPO is Jun 20, 2023, and Jun 21, 2023, respectively.
| Cell Point IPO | Vilin Bio Med IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 15, 2023 | Jun 16, 2023 |
| Issue Close | Jun 20, 2023 | Jun 21, 2023 |
| Basis Of Allotment (Tentative) | Jun 23, 2023 | Jun 26, 2023 |
| Initiation of Refunds (Tentative) | Jun 26, 2023 | Jun 27, 2023 |
| Credit of Share (Tentative) | Jun 27, 2023 | Jun 29, 2023 |
| Listing date (Tentative) | Jun 28, 2023 | Jun 30, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Cell Point IPO P/E ratio is 24.1, as compared to Vilin Bio Med IPO P/E ratio of 24.59.
| Cell Point IPO | Vilin Bio Med IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 91.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.06 | 64.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 24.1 | 24.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹186.86 Cr. | ₹41.85 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 14.76% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 8.58% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.71 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹11.60 | ₹0.10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 10.55% | 1.15% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Cell Point IPO Retail Individual Investors (RII) are offered 23,91,000 shares while in Vilin Bio Med IPO retail investors are offered 23,91,000 shares. Qualified Institutional Buyers (QIB) are offered in Cell Point IPO and in Vilin Bio Med IPO.
| Cell Point IPO | Vilin Bio Med IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 2,52,000 shares | 2,08,000 shares |
| QIB | ||
| NII | 23,91,000 shares | 18,96,000 shares |
| RII | 23,91,000 shares | 18,96,000 shares |
| Employee | ||
| Others | ||
| Total | 47,82,000 shares | 37,92,000 shares |
Cell Point IPO subscribed 6.03x in total, whereas Vilin Bio Med IPO subscribed 2.80x.
| Cell Point IPO | Vilin Bio Med IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 4.11x | 1.28x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 7.92x | 4.31x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 6.03x | 2.80x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
